The New England journal of medicine
Mepolizumab to Prevent Exacerbations of COPD with an Eosinophilic Phenotype.
Oral Regimens for Rifampin-Resistant, Fluoroquinolone-Susceptible Tuberculosis.
Dupilumab for COPD with Blood Eosinophil Evidence of Type 2 Inflammation.
Implications of Race Adjustment in Lung-Function Equations.
Simvastatin in Critically Ill Patients with Covid-19.
Dupilumab for COPD with Type 2 Inflammation Indicated by Eosinophil Counts.
Bronchodilators in Tobacco-Exposed Persons with Symptoms and Preserved Lung Function.
Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19.
Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19.
